These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice. Dai S; Zhuo M; Song L; Chen X; Yu Y; Zang G; Tang Z Immunobiology; 2016 Jul; 221(7):813-21. PubMed ID: 26874581 [TBL] [Abstract][Full Text] [Related]
6. Advancements in CRISPR screens for the development of cancer immunotherapy strategies. Li YR; Lyu Z; Tian Y; Fang Y; Zhu Y; Chen Y; Yang L Mol Ther Oncolytics; 2023 Dec; 31():100733. PubMed ID: 37876793 [TBL] [Abstract][Full Text] [Related]
13. The role of HLA-G for protection of human renal cell-carcinoma cells from immune-mediated lysis: implications for immunotherapies. Bukur J; Seliger B Semin Cancer Biol; 2003 Oct; 13(5):353-9. PubMed ID: 14708715 [TBL] [Abstract][Full Text] [Related]
14. Novel kidney cancer immunotherapy based on the granulocyte-macrophage colony-stimulating factor and carbonic anhydrase IX fusion gene. Hernández JM; Bui MH; Han KR; Mukouyama H; Freitas DG; Nguyen D; Caliliw R; Shintaku PI; Paik SH; Tso CL; Figlin RA; Belldegrun AS Clin Cancer Res; 2003 May; 9(5):1906-16. PubMed ID: 12738749 [TBL] [Abstract][Full Text] [Related]
16. Computational Discovery of Cancer Immunotherapy Targets by Intercellular CRISPR Screens. Yim S; Hwang W; Han N; Lee D Front Immunol; 2022; 13():884561. PubMed ID: 35651625 [TBL] [Abstract][Full Text] [Related]
17. Integrative analysis of CRISPR screening data uncovers new opportunities for optimizing cancer immunotherapy. Li Y; Yang C; Liu Z; Du S; Can S; Zhang H; Zhang L; Huang X; Xiao Z; Li X; Fang J; Qin W; Sun C; Wang C; Chen J; Chen H Mol Cancer; 2022 Jan; 21(1):2. PubMed ID: 34980132 [TBL] [Abstract][Full Text] [Related]
18. In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation. Moreno AM; Fu X; Zhu J; Katrekar D; Shih YV; Marlett J; Cabotaje J; Tat J; Naughton J; Lisowski L; Varghese S; Zhang K; Mali P Mol Ther; 2018 Jul; 26(7):1818-1827. PubMed ID: 29754775 [TBL] [Abstract][Full Text] [Related]
19. Radio frequency ablation combined with interleukin-2 induces an antitumor immune response to renal cell carcinoma in a murine model. Kroeze SG; Daenen LG; Nijkamp MW; Roodhart JM; de Gast GC; Bosch JL; Jans JJ J Urol; 2012 Aug; 188(2):607-14. PubMed ID: 22704448 [TBL] [Abstract][Full Text] [Related]
20. In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer. Dubrot J; Du PP; Lane-Reticker SK; Kessler EA; Muscato AJ; Mehta A; Freeman SS; Allen PM; Olander KE; Ockerman KM; Wolfe CH; Wiesmann F; Knudsen NH; Tsao HW; Iracheta-Vellve A; Schneider EM; Rivera-Rosario AN; Kohnle IC; Pope HW; Ayer A; Mishra G; Zimmer MD; Kim SY; Mahapatra A; Ebrahimi-Nik H; Frederick DT; Boland GM; Haining WN; Root DE; Doench JG; Hacohen N; Yates KB; Manguso RT Nat Immunol; 2022 Oct; 23(10):1495-1506. PubMed ID: 36151395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]